News
The AI presentation software market is growing at a breakneck pace. Verified Market Reports recently valued the global AI PPT Generation Software Market at $1.25 billion in 2024. That figure is ...
Beginners can get started by choosing among hundreds of elegant, downloadable template ... data, Excel can automatically update a live worksheet whenever someone submits a form. Traditional ...
With its advanced AI capabilities, Upmetrics offers a wealth of interactive templates, bringing a new level of engagement and clarity to your ideas. Its intelligent design suggestions and data ... ppt ...
After the slides are generated, you can edit them just like any other presentation in Google Slides, export them for PowerPoint ... templates for business, education, marketing, and nonprofit ...
Boost your revenue with our eight free and customizable forecast sales templates. Plan smarter track performance and make ...
The formation of the Analytical Laboratory Sub-Committee and the addition of a new data model are pivotal steps towards enhancing data sharing and interoperability in the industry.” ...
Nvidia CEO Jensen Huang's rejection of PowerPoint reflects a broader trend among top tech leaders like Elon Musk, Jeff Bezos, and Steve Jobs, who believe ditching slide decks leads to deeper thinking, ...
Many Data Summit speakers have made their presentations available online for attendees to view. Presentations will remain on the website during and after the conference so that you can refer to them ...
ASCO 2025 delivered pivotal updates. In this article, we discuss 8 of the more interesting abstracts from an investment ...
Late-Breaking Data from the Phase 3 ASCENT-04/KEYNOTE ... in relapsed/refractory multiple myeloma during an oral presentation (Abstract #S201). Additional abstracts supporting pipeline therapies ...
The data presented is from a Phase 1/2 clinical study (NCT05636215) aimed at evaluating the safety, tolerability, and preliminary efficacy of IBI354 in participants with advanced solid tumors.
IBI363 shows remarkable efficacy in immune-resistant wild-type nsclc and clinical data suggests better trends in ORR, DCR, PFS and OS at higher doses. We expect longer-term follow-up to bring more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results